ESR1 and cancer: In this same mouse model, the tumors of ERα−/− KO animals reconstituted with ERα-deficient bone marrow failed to exhibit the progression kinetics of animals reconstituted with WT bone marrow, confirming a hematopoietic ERα signaling-dependent mechanism of cancer progression [100].